...
首页> 外文期刊>EBioMedicine >Blood speaks: Personalised medicine profiling for heart failure patients
【24h】

Blood speaks: Personalised medicine profiling for heart failure patients

机译:血液说明:心力衰竭患者的个性化医学分析

获取原文
           

摘要

Heterogeneity in patient populations caused by factors such asage, genetic background, and clinical condition confound prognosticationefforts toward treatment efficacy of coronary artery bypassgrafting (CABG) surgery. The conundrum of patient heterogeneityhas been approached by advances in personalised medicine todevelop tailored therapies. Recent biomedical studies search forpatient-specific biomarker signatures to effectively predict postoperativeresults. In this article of EBioMedicine, Wolfien et al. proposea diagnostic strategy to predict the response of CABG surgerypatients in terms of myocardial repair induced by bone marrowstem cells (BMSC) [1]. Predictive analyses in such a scenario wouldprovide much needed information to identify those individualsmost likely to benefit from BMSC treatment with patient-specificdiagnostic characteristics.
机译:患者群体的异质性,因素如此遗传,遗传背景和临床条件混淆预测预测预测曲目冠状动脉的治疗疗效(CABG)手术。患者异质性的难题是通过个性化药物的进展来涉及剪影量身定制的疗法。最近的生物医学研究搜索特定于特定的生物标志物签名,以有效地预测术后审查。在本文eBiomedicine,Wolfien等人。预防骨髓细胞(BMSC)诱导的心肌修复方面预测CABG外介质的响应的预言诊断策略[1]。这种情况下的预测分析将提供许多需要的信息,以识别那些可能从BMSC治疗中受益于患者特异性诊断特征的人。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号